...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF trading

 I bought quite a few shares in the 40's and after the presentation last week decided not to hold them.  No problem buying or selling so far.  Fidelity has no restrictions

 

Share
New Message
Please login to post a reply